← Back
$LXRX All transactions

LEXICON PHARMACEUTICALS, INC.

M

$ Value

$0

Shares

36,810

Price

$0

Filed

May 13

Insider

Name

DEBBANE RAYMOND

Title

CIK

0001053890

Roles

Director

Transaction Details

Transaction Date

2025-05-13

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. | Each restricted stock unit represents a contingent right to receive one share of common stock.

Filing Info

Accession No.

0001127602-25-014139

Form Type

4

Issuer CIK

0001062822

DEBBANE RAYMOND's History

Date Ticker Type Value
2026-02-25 LXRX $3K
2026-02-23 LXRX $147K
2026-02-20 LXRX $148K
2026-02-19 LXRX $72K
2026-02-18 LXRX $176K
2026-02-17 LXRX $101K
2026-02-13 LXRX $76K
2025-06-03 LXRX A $0
2025-06-03 LXRX A $0
2025-05-13 LXRX M $0

Other Insiders at LXRX (90d)

Insider Bought Sold Last
Invus Global Management, LLC $2.0M 2026-02-02
DEBBANE RAYMOND $723K 2026-02-25
Coiante Scott M
SVP, Chief Financial Officer
2026-02-28
Crum Brian T
SVP, General Counsel & Secr.
2026-02-28
DeFrancesco Lisa
SVP, IR and Corp Comm
2026-02-28
Granowitz Craig B
SVP, Chief Medical Officer
2026-02-28
McDermott Wendy
SVP, Human Resources
2026-02-28
Exton Michael
Chief Executive Officer
2026-02-28
Artal Participations S.a r.l. 2026-02-17
Gopinathan Suma
SVP, Discovery
2026-02-28
Martens Rachel Yap
SVP, Partnerships & Corp Strat
2026-02-28